Showing results (101-110 of 689) with videos related to

Sort By:
Pageof 69
World Journal of Diabetes|September 29, 2023
Recent therapeutic targets for the prevention and management of diabetic complicationsMd Shahidul Islam, Lu Cai, Michael Horowitz
Neurosurgery|October 21, 2006
Intracranial head and neck tumors: endovascular considerations, present and futureRishi Gupta, Ajith J Thomas, Michael Horowitz
American Journal of Otolaryngology|November 11, 2003
Delayed complications of endovascular stenting for carotid blowoutAlfred Simental, Jonas T Johnson, Michael Horowitz
Clinics in Geriatric Medicine|October 10, 2007
Gastric emptying, diabetes, and agingPaul Kuo, Christopher K Rayner, Michael Horowitz
World Journal of Diabetes|April 9, 2024
Glucagon-like-peptide-1 receptor agonists and the management of type 2 diabetes-backwards and forwardsMichael Horowitz, Lu Cai, Md Shahidul Islam
Biomarkers in Medicine|October 14, 2016
Inter-regulation of gastric emptying and incretin hormone secretion: implications for postprandial glycemic controlTongzhi Wu, Christopher K Rayner, Michael Horowitz
Transplantation|December 6, 2003
Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than 10 years after pancreas-kidney transplantationFrank Pfeffer, Michael A Nauck, Oliver Drognitz, et al.
Diabetes, Obesity & Metabolism|November 19, 2016
Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trialsKarolin Bettge, Melanie Kahle, Mirna S Abd El Aziz, et al.
Diabetologia|January 22, 2014
A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatmentMichael A Nauck, Burkhard Haastert, Christoph Trautner, et al.
Diabetes Care|August 11, 2019
Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized TrialMichael A Nauck, Marie Louise Muus Ghorbani, Eskil Kreiner, et al.
Pageof 69